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JNK-miR-203-p63 Signaling
Hung-Lin Chen1, Po-Cheng Chiang1, Chia-Hui Lo1, Yuan-Hsin Lo2, Daniel K. Hsu3,
Huan-Yuan Chen1 and Fu-Tong Liu1,2,3Galectin-7, a member of the b-galactoside-binding protein family, is primarily expressed in stratified epithelial
cells, including keratinocytes. There is information in the literature suggesting a role for this protein in regu-
lation of keratinocyte survival and growth, but the underlying mechanism remains relatively unknown.
Moreover, its expression pattern in the epidermis suggests that it is also involved in the regulation of kerati-
nocyte differentiation. Here, we demonstrate that galectin-7 knockdown results in reduced differentiation and
increased proliferation of keratinocytes. Using microarray and deep-sequencing analyses, we found that
galectin-7 positively and negatively regulates microRNA (miR)-203 and miR-146a expression, respectively. We
show that galectin-7 regulates keratinocyte differentiation and proliferation through miR-203 but not miR-146a.
A knockdown of either galectin-7 or miR-203 in keratinocytes increases expression of p63, an essential tran-
scription factor involved in skin development. Rescue of miR-203 expression in a galectin-7 knockdown model
reduces p63 expression to baseline. Increased galectin-7 expression upregulates c-Jun N-terminal kinase (JNK)
protein levels, which is required for miR-203 expression. Finally, we establish that galectin-7 can be associated
with JNK1 and protect it from ubiquitination and degradation. Thus, our data suggest an intracellular function
of galectin-7: regulation of keratinocyte proliferation and differentiation through the JNK1-miR-203-p63
pathway.
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Epidermal regeneration and homeostasis are important for
maintenance of normal skin function, especially in the
wound healing process (Raja et al., 2007). Regeneration of
keratinocytes and the establishment of the epidermis are
accompanied by keratinocyte migration, proliferation, and
differentiation. Proliferating basal-layer keratinocytes are a
major source of cells for replenishment of the epidermis
(Fuchs and Raghavan, 2002). Aberrant proliferation of kera-
tinocytes is associated with skin diseases, including psoriasis,
atopic dermatitis, and contact dermatitis (Jensen et al., 2004;
Proksch and Brasch, 2012; Tonel and Conrad, 2009), and it
has been linked to neoplastic transformation.
Galectin-7 is a 15-kDa protein belonging to the galectin
family of b-galactoside-binding proteins. It is strongly
expressed in stratified epithelia, hair follicles, and thymic
Hassall’s corpuscles (Madsen et al., 1995; Magnaldo et al.,1Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan;
2Graduate institute of immunology, College of Medicine, National Taiwan
University, Taipei, Taiwan; and 3Department of Dermatology, School of
Medicine, University of California-Davis, Sacramento, California, USA
Correspondence: Fu-Tong Liu, Institute of Biomedical Sciences, Academia
Sinica, Taipei, Taiwan. E-mail: ftliu@ibms.sinica.edu.tw or Department of
Dermatology, University of California, Davis, School of Medicine, 3301 C
Street, Suite 1400, Sacramento, CA 95816, USA. E-mail: fliu@ucdavis.edu
Abbreviations: JNK, c-Jun N-terminal kinase; SCC, squamous cell carcinoma
Received 23 May 2015; revised 19 August 2015; accepted 22 August 2015;
accepted manuscript published online 22 September 2015
Journal of Investigative Dermatology (2016), Volume 136 ª 2015 The A1998). Its expression is induced by p53 and UVB light but
reduced by exogenous retinoic acid. Moreover, its expression
is downregulated in SV40-transformedcells and squamous cell
carcinoma (SCC) cells (Bernerd et al., 1999; Magnaldo et al.,
1995; Polyak et al., 1997). Galectin-7 promotes apoptosis if
transfected into HeLa cells, likely via the c-Jun N-terminal ki-
nase (JNK) signaling pathway (Kuwabara et al., 2002; Madsen
et al., 1995). Galectin-7 is localized in the nucleus and cyto-
plasm. These observations are consistent with its involvement
in intracellular functions (Bernerd et al., 1999; Gendronneau
et al., 2008; Madsen et al., 1995).
Galectin-7 has been shown to contribute to the mainte-
nance of skin homeostasis after skin injury; specifically, ker-
atinocytes in galectin-7 knockout mice displayed a
hyperproliferative phenotype in vivo, when the skin was
exposed to UVB or was wounded (Gendronneau et al.,
2008). However, the underlying mechanism was not eluci-
dated. Moreover, galectin-7 is more weakly expressed in the
proliferating basal-layer cells than in the suprabasal layers
(Magnaldo et al., 1998), suggesting that it may contribute to
the differentiation of keratinocytes, but this possible function
has heretofore not been investigated.
SCC is a common type of skin cancer. UV irradiation and
p53 mutations are strongly associated with its development,
and as mentioned above, both affect galectin-7 expression in
healthy keratinocytes. Intracellular galectins are known to
contribute to various stages of carcinogenesis, such as
apoptosis, tumor cell migration, and metastasis (Liu and
Rabinovich, 2005; Vladoiu et al., 2014). Downregulation ofuthors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.
Figure 1. Galectin-7 knockdown
keratinocytes exhibit reduced
expression of differentiation markers
keratin-1 and keratin-10 and a
hyperproliferative phenotype. (a) The
protein levels of galectin-7, keratin-1,
and keratin-10 in knockdown stable
cell lines, and (bed) the mRNA levels
of galectin-7, keratin-1, and keratin-
10 in stable galectin-7 knockdown
cells were quantified in triplicated
experiments. (e) Time-lapse images of
galectin-7 knockdown cell clones,
parental (P), and empty-vector control
(V). Scale bar ¼ 50 mm. (f) The
numbers of cells from individual
colonies of each group of parental (P),
empty-vector control (V), and four
galectin-7 knockdown cell clones.
The symbols presented on the graph
represent corresponding cells
annotated on the x-axis labeled
below. All statistical analyses were
performed by individually comparing
with the HaCaT parental cell line (P),
ns: not significant, *P < 0.05,
**P < 0.01, ***P < 0.001.
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Galectin-7 Regulates JNK-miR-203-p63 Signalinggalectin-7 in SCCs may play an important role in tumor
progression, but the mechanism is still unknown.
In this study, we demonstrated that galectin-7 knockdown
results in reduced keratinocyte differentiation and increased
keratinocyte proliferation. We then investigated the function
of galectin-7 in keratinocytes by first identifying the micro-
RNAs it regulates during characterization of galectin-7
knockdown keratinocyte cell lines. We found that galectin-
7 positively regulates microRNA (miR)-203 and controls
keratinocyte proliferation and differentiation through this
miRNA, which, in turn, downregulates p63. We also estab-
lished that galectin-7 is associated with and stabilizes JNK,
which positively regulates miR-203 expression. We can
conclude that galectin-7 controls keratinocyte proliferation
and differentiation through the galectin-7-JNK-miR-203-p63
pathway. Our results also provide insights into how galectin-
7 may contribute to the pathogenesis of SCC.
RESULTS
Galectin-7 knockdown reduces keratin-1 and keratin-10
expression and promotes keratinocyte proliferation
To examine the function of galectin-7 in keratinocytes, we
generated galectin-7 knockdown cells from an immortalized
cell line, HaCaT, using four small hairpin RNAeencoding
lentiviruses. The knockdown of galectin-7 was verified by
real-time PCR and immunoblot analysis (Figure 1a and b). Ingalectin-7 knockdown keratinocytes, the mRNA and protein
expression of the differentiation markers keratin-1 and
keratin-10 was reduced significantly (Figure 1a, c, and d). The
keratinocyte line with the lowest galectin-7 expression level
(sh-4) also expressed lower levels of keratin-1 and keratin-10,
as verified by immunoblot and real-time PCR analyses
(Figure 1a, c, and d). To examine whether galectin-7 regu-
lates keratinocyte differentiation through calcium signaling,
we examined calcium-induced differentiation as previously
described (Deyrieux and Wilson, 2007). By immunoblot
analysis, we found that the reduction of keratin-1 and keratin-
10, as well as involucrin, by galectin-7 knockdown was in-
dependent of calcium concentration (Supplementary
Figure S1a online). Here, the vector control also affected
the expression levels of involucrin and keratin-1, but the ef-
fects of galectin-7 were evident, as compared with control.
The fact that other differentiation markers (loricrin, filaggrin)
are not affected is consistent with the information in the
literature that these markers are differentially regulated and
not necessarily all affected as the cells are driven to differ-
entiate (Moravcova et al., 2013; Reichelt and Magin, 2002).
In addition, we examined the expression of epithelial-
mesenchymal transition markers, and found that the expres-
sion of E-cadherin, N-cadherin, claudin-1, b-catenin, snail,
and slug was either not affected appreciably or affected var-
iably among knockdown clones (Supplementary Figure S1b).www.jidonline.org 183
Figure 2. miR-146a and miR-203 are
differentially expressed in galectin-7
knockdown keratinocytes, whereas
miR-203 knockdown cells show
reduced expression of keratin-1 and
keratin-10. The amounts of miR-203
(a, c) and miR-146a (b, d) in four
stable galectin-7 knockdown cell
clones and two control cell clones
(a, b), stable miR-203 knockdown (c),
and miR-146a overexpression (d) cells
were quantified and compared with
their vector controls and parental
control. (e, f) The mRNA levels of
keratin-1 and keratin-10 in two stable
miR-203 knockdown cell clones and
one stable miR-146a-overexpressing
cell clone. All experiments were
carried out at lease in triplicate, and
statistical analyses were performed by
individually comparing with the
HaCaT parental cell line (P), ns: not
significant, **P < 0.01, ***P < 0.001.
miR, microRNA.
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184On the basis of its effect on keratin-1 and keratin-10, we
conclude that galectin-7 is a positive regulator of keratino-
cyte differentiation.
We further examined whether the decrease in keratin-1
and keratin-10 correlated with the cell’s proliferative ability,
as suggested by previous studies (Kartasova et al., 1992;
Pivarcsi et al., 2001). We quantified the cell proliferation
ability of these lines for 24 hours after they reached the G1
phase from the single-cell stage, by long-term time-lapse
imaging analysis (Hinchcliffe, 2005). We found that galectin-
7 knockdown cells proliferated faster than control cells,
as indicated by the higher progeny cell numbers (Figure 1e
and f). This was confirmed by examining the reconstituted
human epidermis derived from galectin-7 knockdown cells
(Supplementary Figure S1c). In addition, we investigated the
role of galectin-7 in normal human primary keratinocytes
(HEKn) and obtained results similar to those for HaCaT cells.
The galectin-7 knockdown clones (si-1 and si-3) displayed
reduced keratin-1 and keratin-10, as well as increased cell
proliferation as compared with control clones (siNC).
Another clone derived from HEKn treated with galectin-7
siRNA, but with an unaffected galectin-7 level (si-2), alsoJournal of Investigative Dermatology (2016), Volume 136served as the control (Supplementary Figures S2aed online).
Our results suggest that galectin-7 suppresses keratinocyte
proliferation and promotes keratinocyte differentiation.
Galectin-7 regulates miRNA expression in keratinocytes
MicroRNAs are crucial regulators of keratinocyte differentia-
tion and proliferation (Yi et al., 2008). Several miRNAs are
differentially expressed in lesions in skin diseases (Sonkoly
et al., 2007). We studied the miRNA expression by micro-
array and small-RNAdeep-sequencing analyses. FourmiRNAs
were differentially expressed, namely miR-10b, miR-146a,
miR-203, and miR-4270; they were expressed greater than
fourfold higher or lower in galectin-7 knockdown cells (sh-1)
compared with both parental and empty-vector control cells
(Supplementary Table S1 online). We found 10 miRNAs by
means of small-RNA deep-sequencing that had a greater than
or equal to twofold differential reads ratio, with the cutoff
at 1,000 reads (Supplementary Table S2 online). Only two
miRNAs, miR-146a and miR-203, were found to be differen-
tially expressed in galectin-7 knockdown keratinocytes
according to both microarray (with a fourfold change) and
deep sequencing analyses (with a reads ratio of >2 or <0.5).
Figure 3. Ectopic expression of miR-
203 can restore the galectin-7
knockdown phenotype of keratin-1
expression. (a) The proliferated miR-
203 knockdown clones were
monitored using time-lapse
microscopy. Scale bar ¼ 50 mm. (b)
The proliferation rate of miR-203
knockdown clones was quantified by
counting the number of progeny cells
24 hours after the first round of
division (n ¼ 20). The symbols
presented on the graph represent
corresponding cells annotated on the
x-axis labeled below. (ceh) HaCaT
cells were transiently transfected with
indicated plasmids and their
corresponding control plasmids. (cef)
Real-time PCR and (g, h) immunoblot
analysis are presented. All
experiments were performed at least
in triplicate, and the statistical
analyses were performed by
individually comparing with HaCaT
parental cells (P), ns: not significant,
***P < 0.001. miR, microRNA.
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203 were further confirmed by real-time PCR in all four
galectin-7 knockdown clones (Figure 2a and b). In addition,
the regulation of miR-203 and miR-146a expression by
galectin-7 was confirmed using HEKn, in which both keratin-
1 and keratin-10 were also reduced by galectin-7 knockdown
(Supplementary Figure S2a-f).
Reduced miR-203 expression in galectin-7-knockdown
keratinocytes affects cell differentiation and proliferation
To determine the role of galectin-7-controlled miRNAs in ker-
atinocyte proliferation and differentiation, we generated stablemiR-203knockdownandmiR-146a-overexpressingHaCaTcell
lines. The effective knockdown and overexpression of these
miRNAs were confirmed by real-time PCR (Figure 2c and d).
Two miR-203 knockdown lines, but not miR-146a over-
expressing lines, showed reduced expression of keratin-1 and
keratin-10 (Figure 2e and f). By means of time-lapse cell prolif-
eration analysis, we demonstrated that miR-203 knockdown
cells exhibited a hyperproliferative phenotype similar to
galectin-7 knockdown cells (Figure 3a and b).
To examine whether the galectin-7 control of keratinocyte
differentiation is dependent on miR-203 expression, we
ectopically expressed miR-203 in galectin-7 knockdownwww.jidonline.org 185
Figure 4. Galectin-7 regulates
DNp63 expression through miR-203.
(a) The p63 protein levels; (b) the
galectin-3, galectin-7, p63, and
keratin-1 protein levels; (c)
immunofluorescence of p63; and (d)
the relative ratio of p63-positive cells
in galectin-7 and miR-203 knockdown
cells after normalization to parental
cells are presented. The statistical
analyses were performed in triplicated
experiments by individually
comparing with the HaCaT parental
cells, *P < 0.05, **P < 0.01, ***P <
0.001. Scale bar ¼ 200 mm. (e) The
relative ratio of p63-positive cells in
transfected galectin-7 knockdown
cells (sh-1) by indicated plasmids was
normalized to sh-1 cells. The
statistical analyses were performed by
individually comparing with the
galectin-7 knockdown cell line (sh-1).
ns: not significant, **P < 0.01. (f) The
p63 protein levels of transiently
transfected HaCaT cells. miR,
microRNA.
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186cells. This action restored keratin-1 expression (Figure 3c).
Furthermore, overexpression of galectin-7 increased the
expression of keratin-1, and this effect was reversed by
knocking down miR-203 (Figure 3d). Our data suggest that
miR-203 acts downstream of galectin-7 to regulate keratin-1
expression. In each case, galectin-7 levels were measured by
real-time PCR and immunoblot analyses (Figure 3eeh).
Overexpression of miR-203 in HaCaT cells had no significant
effect on keratin-1 expression (Figure 3c and g). This result
could be due to the abundance of endogenous miR-203 in
keratinocytes, which could make the effect of the exogenous
(transfected) miRNA relatively weak. Moreover, the increase
in keratin-1 expression induced by ectopic expression of
galectin-7 could be reversed by knocking down miR-203
(Figure 3d and h). Finally, the expression level of miR-203
in galectin-7 knockdown cells can be restored by over-
expression of miR-203 and overexpression of galectin-7 can
induce miR-203 expression (Supplementary Figure 3a and b
online). Taken together, these data suggest that galectin-7 and
miR-203 act on the same pathway to regulate keratinocyte
differentiation. However, in view of the finding described
above that overexpression of miR-203 in HaCaT cells had noJournal of Investigative Dermatology (2016), Volume 136significant effect on keratin-1 expression, we cannot exclude
the possibility that galectin-7 may need to engage other
pathways to regulate keratin-1 expression (see the Discussion
section).
Increased DNp63 expression in galectin-7 knockdown cells
can be restored by ectopic miR-203 expression
To determine how galectin-7 regulates keratinocyte prolifer-
ation and differentiation through miR-203, we examined the
expression of a known miR-203 target, DNp63, in galectin-7
knockdown cells. This target protein belongs to the p53
family, and it is an essential transcription regulator in skin
development (Yang et al., 1999). In stable galectin-7 knock-
down cells, we observed increased expression of the DNp63
protein (Figure 4a). A transient knockdown of galectin-7, but
not galectin-3, resulted in increased expression of DNp63,
along with decreased expression of keratin-1 (Figure 4b).
Consistently, an siRNA-mediated knockdown of galectin-7 in
HEKn cells resulted in increased expression of DNp63
(Supplementary Figure 2b).
Consistent with the above results, immunofluorescence
staining revealed that a knockdown of galectin-7 or miR-203
Figure 5. JNK1 is required for miR-
203 expression and downregulated at
the protein level in galectin-7
knockdown cells. (a, b) The
knockdown of JNK1 and p63 mRNA
levels. (c, d) Expression of miR-203 in
HaCaT cells with a transient
knockdown of either JNK1 or p63. (e)
The relative mRNA levels of JNK1 in
galectin-7 knockdown cells. (f) The
protein levels of JNK1 in galectin-7
knockdown cells. The relative fold
changes of JNK1, p63, and miR-203 in
JNK1 and p63 knockdown HaCaT
cells were normalized to the empty-
vector control. The statistical analyses
were performed by individually
comparing with the HaCaT parental
cell line (P), ns: not significant, ***P <
0.001. JNK, c-Jun N-terminal kinase,
miR, microRNA.
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positive cells (Figure 4c and d). Moreover, miR-203 knock-
down cells contained a similar percentage of DNp63-positive
cells to that of galectin-7 knockdown cells (Figure 4d).
Next, we demonstrated that ectopic expression of miR-203
in galectin-7 knockdown cells (sh-1) could reduce the per-
centage of DNp63-positive cells and the protein expression
levels of DNp63 (Figure 4e and f). Thus, we verified that p63
is a target of miR-203 and is regulated by the galectin-7-miR-
203 signaling pathway.
JNK1 is required for miR-203 expression in keratinocytes
Previous reports suggested that miR-203 expression is regu-
lated by p53 and mitogen-activated protein kinase (McKenna
et al., 2010; Melar-New and Laimins, 2010). Differentiation
inducing stimulations (12-O-tetradecanoylphorbol-13-
acetate and calcium) can also regulate miR-203 expression
through JunB and c-Jun in complex with activator protein 1
(Sonkoly et al., 2010). JNK is an upstream regulator of c-Jun
and may participate in regulating miR-203. We thus hy-
pothesized that JNK1 signaling is required for miR-203
expression in HaCaT cells. A small hairpin RNAemediated
knockdown of JNK1, but not p63, resulted in a reduction in
miR-203 expression, suggesting that miR-203 is regulated by
JNK1 (Figure 5aed). By real-time PCR analysis of galectin-7
knockdown cell lines, we found no difference in JNK1
mRNA levels, as compared with control (Figure 5e).However, by immunoblot analysis, we found that the protein
levels of JNK1 were reduced in galectin-7 knockdown HaCaT
(Figure 5f) and HEKn cells (Supplementary Figure 2b). Our
results suggest that galectin-7 directly or indirectly regulates
JNK1 protein stability.
Galectin-7 colocalizes with JNK1 and protects it from
ubiquitination
Other studies have shown that the JNK1 protein is regulated
during cell cycle progression through a ubiquitin-dependent
proteasome pathway (Gutierrez et al., 2010). To examine
whether galectin-7 regulates JNK1 degradation and ubiq-
uitination in HaCaT cells through the proteasome degrada-
tion pathway, we first determined whether the reduced JNK1
expression in galectin-7 knockdown cells was due to pro-
teasome degradation, by applying the proteasome inhibitor
MG-132. MG-132 treatment of galectin-7 knockdown cells
restored the JNK1 protein levels (Figure 6a), suggesting that
the decrease in galectin-7 enhances the degradation of JNK1
by the proteasome.
Next, we analyzed JNK1 immunoprecipitated from HeLa
cells, which had been co-transfected with histidine-tagged
ubiquitin and galectin-7 and subsequently treated with
MG-132. We found that JNK1 was ubiquitinated, and
overexpression of galectin-7 reduced the extent of ubiq-
uitination (Figure 6b, lanes 4 and 5). These data are also
consistent with our immunostaining results usingwww.jidonline.org 187
Figure 6. Galectin-7 interacts with JNK1 and inhibits its ubiquitination and degradation. (a) Immunoblot analysis of JNK1, galectin-7, and tubulin in
galectin-7 knockdown cells treated with or without MG-132. (b) HeLa cells containing ectopically expressed JNK1-GFP were treated with MG-132, and
the ubiquitination of immunoprecipitated JNK1-GFP was detected by using an anti-his antibody to detect his-tag-ubiquitin. Lanes 1e3 served as control.
(c) Co-immunoprecipitation of JNK1 with galectin-7 from HaCaT cells was performed by using an anti-galectin-7 antibody. (d) The interaction of JNK1 and
galectin-7 as demonstrated by a mammalian two-hybrid system. The statistical analysis was performed by comparing between vector controls (pACTþpBIND)
with pACT-Gal-7þpBIND-JNK1 co-transfected with pGL3-Luciferase reporter. ***P < 0.001. (e) Immunofluorescence of galectin-7 and JNK1 was performed
using confocal microscopy with Z-stack sectioning. Scale bar ¼ 10 mm. JNK, c-Jun N-terminal kinase.
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188antibodies against galectin-7, JNK1, and ubisquitin, quan-
tified by high-content image analysis. The percentage of
co-localization of JNK1 with ubiquitin signals increased
from 30% in the parental and empty-vector control cells to
50% in galectin-7 knockdown cells (Supplementary
Figure S4a and b online).
Galectin-7 interacts with JNK1
To determine whether galectin-7 can directly interact
with JNK1 and affect its ubiquitination, we performed
co-immunoprecipitation, mammalian two-hybrid, andJournal of Investigative Dermatology (2016), Volume 136confocal-microscopy assays. We found that ectopically
expressed JNK1 in HeLa cells could be co-
immunoprecipitated with galectin-7 (Figure 6b, lanes 5 and
6). Co-immunoprecipitation of JNK1 and galectin-7 was also
demonstrated in HaCaT cells (Figure 6c). A mammalian two-
hybrid system using the fusion proteins JNK-1Gal4DB and
galectin-7-Vp16 confirmed the JNK1-galectin-7 interaction
(Figure 6d). In addition, confocal immunofluorescence
staining showed that JNK1 was mainly located in the nucleus,
where it colocalized with galectin-7. The threshold Pearson’s
correlation coefficient of nuclear galectin-7 and JNK1, as
H-L Chen et al.
Galectin-7 Regulates JNK-miR-203-p63 Signalingdetermined by the method used by Barlow et al. (2010), was
0.655  0.09 (mean  SD, n ¼ 4; Figure 6e).
DISCUSSION
Although galectins are expressed in intracellular compart-
ments, and some have been shown to perform important
intracellular functions (Liu et al., 2002; Vladoiu et al., 2014),
other studies have mostly dealt with the extracellular func-
tions of galectins. Galectin-7 is known to reside in both the
nucleus and cytoplasm of keratinocytes (Inagaki et al., 2008;
Kuwabara et al., 2002) and was shown to bind to Bcl-2
intracellularly (Villeneuve et al., 2011). In this study, we
uncovered an intracellular function of galectin-7 in kerati-
nocytes: regulation of cell proliferation and differentiation by
maintaining homeostasis of miRNA signaling pathways.
By analyzing cell clones ectopically expressing galectin-7
and miR-203, we found evidence that galectin-7 partici-
pates in the regulation of miR-203, and gained some insight
into the mechanisms involved. Overexpression of galectin-7
had no significant effects on the biosynthesis of miR-203
(data not shown). Therefore, we believe that galectin-7 reg-
ulates miR-203 at the transcriptional level. The results of
chromatin immunoprecipitation and real-time PCR experi-
ments did not show direct binding of galectin-7 to the miR-
203 promoter (data not shown). It is likely that galectin-7
regulates expression of miRNAs via proteins crucial for the
biosynthesis of the specific miRNAs. Indeed, we identified
one such protein, JNK1, which is downregulated at the pro-
tein level, but not at the mRNA level, in galectin-7 knock-
down cells. We previously found that overexpression of
galectin-7 resulted in enhanced JNK1 phosphorylation
(Kuwabara et al., 2002), without affecting the levels of JNK1.
The difference might reflect varying functions of galectin-7 in
different cell types. Moreover, a knockdown of JNK1 reduced
miR-203 expression. Thus, it appears that galectin-7 regulates
miR-203 expression by controlling the turnover of JNK1.
It has been reported that JNK1 and JNK2 are degraded by
the large multimeric anaphase-promoting complex with the
coactivator protein Cdh1 during cell cycle progression,
through a ubiquitination-dependent pathway (Gutierrez
et al., 2010). We found that galectin-7 suppresses JNK1
ubiquitination, and the degradation of JNK1 is sensitive to the
proteasome inhibitor MG-132. However, these results may
not totally exclude the possibility that galectin-7 may also
participate in other protein degradation systems such as
autophagy. In addition, as observed for both galectin-1 and
galectin-3 (Inagaki et al., 2008; Vyakarnam et al., 1997; Yu
et al., 2002), galectin-7 can shuttle between the nucleus
and cytoplasm, although whether this phenomenon is rele-
vant to the regulation of JNK expression remains to be
clarified.
With regard to the role of miR-203 in mediating galectin-
7’s regulation of keratinocyte differentiation, we demon-
strated (1) ectopic expression of miR-203 can restore the
expression level of keratin-1 in galectin-7 knockdown cells,
and (2) the induction of keratin-1 expression by ectopically
expressed galectin-7 is suppressed by miR-203 knockdown.
These data support that galectin-7 regulates keratin-1
expression through the miR-203 pathway. However,
we need to address our finding that ectopic expression ofmiR-203 in HaCaT cells had no effect on keratin-1 expres-
sion. This could be due to both the high abundance of
miR-203 and limited availability of target p63 mRNA in
keratinocytes. Thus, miR-203 knockdown produced more
effects than its overexpression. This general phenomenon has
been reported in other studies (e.g., Arvey et al., 2010).
Nevertheless, ectopic expression of galectin-7 is known to
induce expression of a number of genes, as reported in our
previous studies (Kuwabara et al., 2002). Galectin-7 may
promote keratinocyte differentiation through one or more of
these other genes.
In the studies of galectin-7 knockout mice subjected
to stressful conditions including UVB irradiation or tail
injury, Gendronneau et al. (2008) concluded that galectin-7
suppresses keratinocyte proliferation and survival. There, an
increase of ki67-positive cells was observed in the epidermis
of galetin-7-deficient mice, compared with wild-type mice.
Thus, galectin-7 deficiency results in a hyperproliferative
phenotype when keratinocytes are subjected to stress.
However, the underlying mechanism was not elucidated. In
our studies, we provided evidence that galectin-7 negatively
regulates keratinocyte proliferation which is consistent with
the findings described above. This is based on a single cell
proliferation assay and p63 expression analyses in a ho-
meostasis condition. Moreover, we established the pathway
through which galectin-7 regulates keratinocyte proliferation.
Our study sheds some light on the relationship between
galectin-7 and SCC, which is known to be associated with
UV irradiation. Galectin-7 is a p53-inducible gene (Polyak
et al., 1997), and it can be induced by UV irradiation. In
addition, galectin-7 is downregulated in SCC (Magnaldo
et al., 1998). Both p53 and DNp63 are transcription factors
participating in the regulation of keratinocyte apoptosis,
proliferation, and differentiation (Polyak et al., 1997). In SCC,
the p53 family of proteins (p53, p63, and p73) has distinct but
interconnected functions; p53 is often mutated, but the
DNp63 isoform is overexpressed (Missero and Antonini,
2014). Moreover, in healthy keratinocytes, SCC cell lines,
and SCC, DNp63a transactivates PIR2/Rnf14B and thereby
regulates epithelial cell proliferation. Unlike p53, which is a
tumor suppressor, the major isoform of p63, DNp63a, pro-
motes proliferation of healthy keratinocytes and expression of
the SCC-suppressing gene Notch1 (Yugawa et al., 2010).
Galectin-7 may also be linked to SCC through miR-203,
which is downregulated in SCC (Dziunycz et al., 2010), but
induced by UV irradiation (Syed et al., 2013). In addition, the
expression of DNp63 is regulated by miR-203 (Yi et al.,
2008). Thus, our data suggest that downregulation of
galectin-7 in keratinocytes (caused by mutations in p53) may
contribute to the pathogenesis of SCC, because the expres-
sion of DNp63 is increased, resulting in enhanced cell pro-
liferation. Moreover, our study shows a link between p53 and
DNp63 through the galectin-7-JNK1-miR-203 pathway.
It should be noted that galectin-7 may have opposite func-
tions in different types of cancer (St-Pierre et al., 2012). Ectopic
expression of galectin-7 in a colon carcinoma cell line was
shown to suppress tumor growth (Ueda et al., 2004). On the
other hand, galectin-7 is overexpressed in aggressive mouse
lymphoma cells, and its expression level correlates with can-
cer progression (Moisan et al., 2003). In breast cancer,www.jidonline.org 189
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190overexpression of galectin-7 enhances spontaneousmetastasis
(Demers et al., 2010). These variable roles of galectin-7 are
possibly due to the fact that galectin-7 expression is differen-
tially regulated in various cancers, and this protein may target
dissimilar pathways in different cell types.
In summary, we examined the function of galectin-7 in
keratinocytes and uncovered a regulatory pathway—
involving miR-203 and p63—that controls cell proliferation
and differentiation. Furthermore, we demonstrate that
galectin-7 regulates miR-203 expression through a direct
interaction with JNK1, and that this interaction protects JNK1
from ubiquitination and degradation. In addition, our data
suggest that galectin-7 may be involved in the pathogenesis
of skin cancers such as SCC.
MATERIALS AND METHODS
Cell culture and generation of galectin-7 knockdown
stable cells
The HaCaT cell line (Boukamp et al., 1988) was cultured in Dul-
becco’s modified Eagle medium supplemented with 10% fetal
bovine serum (GIBCO, Gaithersburg, MD). Lentivirus-encoded small
hairpin RNAs against human galectin-7 were obtained from the
National RNAi Core Facility (Taiwan). After infection with a small
hairpin RNAecarrying lentivirus for 3 days, puromycin was used for
selection of the transfected cells. Subsequently, four cell clones were
cultured in a puromycin-free medium for 2 weeks before analysis.
Cell proliferation quantified by time-lapse microscopy
A time-lapse microscope, Leica MDI600B, was used to monitor
long-term imaging of cell proliferation (Hinchcliffe, 2005; Nagy
et al., 2010). Images of cells were automatically captured every 10
minutes for 3 days using a 10 objective lens. Keratinocytes were
seeded at a density of 10,000/ml in six-well plates without syn-
chronization, and proliferation was examined. Images of single cells
were tracked until they proliferated into the two-cell stage, which is
considered to be at the G1 phase. From this point, the two cell
clusters were tracked for 24 hours and the number of cells origi-
nating from the clusters was quantified at that endpoint. Twenty
clusters each from the HaCaT parental, vector control, and galectin-
7 knockdown cells were examined. The images were analyzed using
MetaMorph software (Mehes et al., 2012).
Generation of miR-203 knockdown and miR-146a stably
overexpressing cell clones
To downregulate miR-203 in HaCaT cells, we used an antisense
miR-203 vector (MZIP203-PA-1) and an miRZip scrambled hairpin
control vector (MZIP000-PA-1) from System Biosciences (SBI; CA).
HaCaT cells were transfected with the pZip control and pZip-203
vectors using the Effectene reagent (Qiagen; MD). Three days after
the transfection, transfected cells were enriched by sorting based on
the copGFP reporter, followed by puromycin selection. Two pooled
miR-203 knockdown cell clones (Zip203-1 and Zip203-2) were
generated via independent transfection followed by the selection
procedures described above.
We used an miR-146a-overexpressing vector (PMIRH146aPA-2)
and a scrambled control hairpin in pCDH-CMV-MCS-EF1-copGFP
(CD511B-1) from SBI to generate stable miR-146a-overexpressing
and control cell clones, respectively, using a similar protocol as
describe above.Journal of Investigative Dermatology (2016), Volume 136Immunofluorescence analysis of p63
Immunofluorescence of p63 was performed on confluent stable
galectin-7 and miR-203 knockdown cell clones. To calculate the
ratio of p63-positive cells, 4,6-diamidino-2-phenylindole staining
was used to visualize and count the cell nuclei. Confocal imaging
was conducted under a PerkinElmer Ultraview RS microscope and
the Volocity software was used to quantify the number of p63-
positive cells. More than 900 cells, randomly selected from
different visual fields, were analyzed to determine the percentages of
p63-positive cells.
MG-132 treatment
To study the role of proteasome degradation, cells were treated with
or without 10uM MG-132 (Selleckchem, TX) for 5 hours. HeLa cells
containing ectopically expressed JNK1-GFP were treated with MG-
132, and the ubiquitination of immunoprecipitated JNK1-GFP was
detected by immunoblot, using an anti-his antibody to detect his-
tag-ubiquitin.
Mammalian two-hybrid analysis
We employed the CheckMate Mammalian Two-Hybrid (Promega,
CA) system. Galectin-7 and JNK1 were subcloned into the pACT and
pBind vector, respectively. These plasmids, along with the reporter
pGL5luc vector, were cotransfected into 293T cells, and the Dual-
Luciferase Reporter Assay System was used to measure luciferase
activity. The data were recorded as counts per second using a
SpectraMax luminescence microplate reader.
Statistical analysis
Quantitative results were analyzed by using the Prism 6 software
(GraphPad Software, CA). One-way analysis of variance with Tukey’s
post hoc test was used to analyze the differences between the groups
and pairs. In addition, an unpaired two-tailed Student’s t-test was
used to analyze the differences between pairs of data. P-values <
0.05 denote statistical significance.
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